Editors' ChoiceCancer

Paper of note in Science Translational Medicine 9 (398)

See allHide authors and affiliations

Sci. Signal.  18 Jul 2017:
Vol. 10, Issue 488, eaao3798
DOI: 10.1126/scisignal.aao3798

This week’s article describes an epigenetic target for treating kidney cancer.

CANCER

An “EZ” target for kidney cancer

Chakraborty et al. discovered that inhibiting the histone methyltransferase EZH1 might kill tumor cells in patients with VHL-deficient clear cell renal cell carcinoma.

Highlighted Article

View Abstract

Navigate This Article